Dr. Acosta's genetic test MyPhenome can categorize individuals into types of weight gain, predicting response to semaglutide with 75% accuracy, aiding in personalized weight-loss treatment without trial and error.
Identifying those who will benefit from drugs like Wegovy can improve patient outcomes, reduce costs, and manage access better, potentially revolutionizing obesity treatment approaches.
Collection
[
|
...
]